T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
1326
Happen Inc
HAPN
$2.27B
| $7.66M | ﹤0.01% |
356,289
+39,348
| +12% | +$1.13M |
|
1327
Markel Group
MKL
$22.8B
| $7.57M | ﹤0.01% |
7,940
+280
| +4% | +$261K |
|
|
PDCO
1328
DELISTED
Patterson Companies, Inc.
PDCO
| $7.48M | ﹤0.01% |
156,240
-658,360
| -81% | -$30.3M |
|
|
DISH
1329
DELISTED
DISH Network Corp.
DISH
| $7.45M | ﹤0.01% |
142,253
+14,422
| +11% | +$705K |
|
1330
Sunrun
RUN
$2.37B
| $7.41M | ﹤0.01% |
+1,249,595
| New | +$8.26M |
|
1331
Comscore
SCOR
$91.6M
| $7.39M | ﹤0.01% |
15,484
-555
| -3% | -$332K |
|
1332
Gray Television
GTN
$520M
| $7.39M | ﹤0.01% |
681,500
-1,900
| -0.3% | -$22.4K |
|
1333
Transocean
RIG
$6.39B
| $7.38M | ﹤0.01% |
620,660
-1,320
| -0.2% | -$13.5K |
|
1334
Phibro Animal Health
PAHC
$1.38B
| $7.32M | ﹤0.01% |
392,380
-12,400
| -3% | -$259K |
|
|
OXFD
1335
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.32M | ﹤0.01% |
813,215
-8,231
| -1% | -$80.6K |
|
1336
PRA Group
PRAA
$762M
| $7.27M | ﹤0.01% |
301,170
+2,200
| +0.7% | +$61.5K |
|
|
PRAH
1337
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.26M | ﹤0.01% |
+173,850
| New | +$8.01M |
|
1338
First Solar
FSLR
$24B
| $7.25M | ﹤0.01% |
149,655
+400
| +0.3% | +$21.3K |
|
1339
IPG Photonics
IPGP
$3.57B
| $7.17M | ﹤0.01% |
89,679
-192
| -0.2% | -$16.9K |
|
1340
Children's Place
PLCE
$53.4M
| $7.17M | ﹤0.01% |
89,360
+1,850
| +2% | +$139K |
|
|
FLIR
1341
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $7.13M | ﹤0.01% |
230,400
-20,710
| -8% | -$647K |
|
1342
NETSCOUT
NTCT
$2.89B
| $7.07M | ﹤0.01% |
317,600
-5,868,230
| -95% | -$136M |
|
1343
Hubbell
HUBB
$26.8B
| $7.03M | ﹤0.01% |
66,659
-1,196
| -2% | -$126K |
|
1344
Hudbay
HBM
$11.8B
| $7.02M | ﹤0.01% |
+1,476,900
| New | +$6.18M |
|
1345
Warner Bros
WBD
$69.6B
| $7M | ﹤0.01% |
277,230
-10
| -0% | -$273 |
|
|
FRC
1346
DELISTED
First Republic Bank
FRC
| $6.99M | ﹤0.01% |
99,833
+17,918
| +22% | +$1.24M |
|
1347
Clearway Energy Class C
CWEN
$7.02B
| $6.97M | ﹤0.01% |
446,870
+10,900
| +3% | +$166K |
|
1348
Wingstop
WING
$3.1B
| $6.93M | ﹤0.01% |
+254,259
| New | +$6.61M |
|
1349
Autohome
ATHM
$2.6B
| $6.88M | ﹤0.01% |
342,256
-1,305,208
| -79% | -$34.9M |
|
|
QVCGA
1350
DELISTED
QVC Group Inc Series A
QVCGA
| $6.69M | ﹤0.01% |
5,432
-8
| -0.1% | -$10.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.